HARARE - The Zimbabwe HIV and AIDS Activist Union Community Trust ZHAAU-CT is setting up committees led by people living with HIV with the intention of monitoring access to and availability of AIDS services in the country's heath care centres. The initiative, which was launched at St Paul's Msami hospital in Mrewa last week, will see the AIDS activists reporting shortages of Anti-Retroviral drugs, cases of stigma and discrimination happening in hospitals as well as monitoring drug adherence among those on treatment. ZHAAU-CT president Stanley Takaona (HIV positive) at the launch said the initiative was not a witch-hunting exercise.
UNAIDS, UNICEF, UNFPA, WHO, PEPFAR, the Global Fund to Fight AIDS, Tuberculosis and Malaria, the MTV Staying Alive Foundation and youth movements represented by PACT and Y+ join President Uhuru Kenyatta to launch All In, a new platform for action against the adolescent AIDS epidemic.
NAIROBI, 17 February 2015—While major advances have been made in almost every area of the response to HIV, progress for adolescents is falling behind, said leaders in the global response to end the AIDS epidemic.
AIDS has become the leading cause of death for adolescents in Africa and the second leading cause of death among adolescents globally. Just one in four children and adolescents under the age of 15 have access to life-saving antiretroviral treatment. Deaths are declining in all age groups, except among 10–19 year olds.
People taking antiretroviral drugs have been urged to adhere to their treatment regimens so that they do not develop resistance, reversing recovery benefits and incurring huge health care costs, an Aids expert has said. “Adherence is critical in suppressing the virus and the level of drug concentration should be maintained so that treatment becomes effective,” said Owen Mugurungi, the director of Aids and TB in the Health ministry. He said HIV treatment success was hinged on sticking to specific time of taking the ARVs and on a daily basis without fail.
“If one defaults on treatment for whatever reason, the virus mutates and becomes resistant to drugs being taken. It then becomes expensive to move a patient from the first line of treatment to the second line.”
New Friends’ paper highlights innovative ways countries are mobilising health resources to fight AIDS, Tuberculosis and Malaria
Washington, D.C., February 10, 2015 — In a report released Tuesday, Friends of the Global Fight Against AIDS, Tuberculosis and Malaria highlights ways in which Global Fund implementing countries are increasing domestic investments in health. The report, titled Innovation for Greater Impact: Exploring Resources for Domestic Health Funding in Africa, illustrates how, through a variety of approaches, African governments are mobilizing additional resources to fight HIV/AIDS, tuberculosis and malaria.
“Impressive global progress has been made against the three diseases in recent decades and African governments are really stepping up. They have increased their domestic health financing by 150 percent,” said Friends’ President Deb Derrick. “But the fight is not yet over. To sustain momentum and ultimately defeat these diseases, increased funding will need to come from implementing countries and the Global Fund is working to facilitate this.”
HARARE - Government is mooting an ambitious roll-out of anti-retroviral drugs (ARVs) to every Zimbabwean who tests HIV positive.
David Parirenyatwa, the Health and Child Care minister, told delegates to a Southern Africa HIV and AIDS Information Dissemination Service (SafAIDS) community event in Mhondoro-Ngezi last Friday that all HIV positive people should access the life-prolonging treatment despite their CD-4 count.“We want ARVs to be everywhere and we don’t want to hear about shortages,” he said. “Now we are saying we need every HIV positive person to be on ARVs.”
THE ministry of health has launched an ambitious US$100 million male circumcision programme that is expected to see at least 80 percent of the male population being voluntarily circumcised.The development was confirmed by health minister David Parirenyatwa while launching the accelerated operational plan 2014–2018 and the revised policy guidelines at Green Park in Marondera today.
The SADC Member States and partners in the national response to HIV and AIDS have been urged not to shift HIV and AIDS resources to other areas as the pandemic is still far from over. Speaking at the official opening of the ongoing joint meeting of SADC Ministers of Health and Ministers responsible for HIV and AIDS in Victoria Falls on the 14th of January 2015, SADC Chairperson Health Ministers, Minister of Health and Child Care, Dr David Parirenyatwa said that HIV and AIDS remains one of the ‘triple diseases burden alongside TB and Malaria.
GOVERNMENT is with effect from this month switching all people on HIV treatment to a new one of one tablet per day from the previous three pills to make it easier for patients not to default on taking medication. The new single tablet has a combination of three drugs (Tenofovir/Lamivudine/Efavirenz TLE), a departure from the previous complicated treatment of three different tablets namely Tenofovir, Lovovidine and Nevirapine (TLN). The government estimates that 1. 3 million people are living with HIV, of which 187 000 of them are children under the age of 15 years.
HARARE - A partnership by the National AIDS Council (NAC), NatPharm and some pharmarcies in the private sector has resulted in the drop in prices of anti-retroviral drugs (ARVs) that will now be accessed for US$17 down from an average US$55 currently prevailing. The development comes after NAC launched the increased access to treatment plan, which will see them procure ARVs in bulk at the manufacturing rate.The drugs will then be distributed by NatPharm and licensed pharmacies in the private sector.
NAC Zimbabwe is set to adopt new World Health Organization (WHO) Antiretroviral Therapy (ART) guidelines which have reviewed the stage at which a person living with HIV can be initiated on ART. The guidelines now states that a person living with HIV can be initiated on Antiretroviral therapy if his or her CD4 count is 500 or below (up from 350). Zimbabwe is currently using the 2010 WHO guidelines which use CD4 count of 350 for ART initiation. National AIDS Council Chief Executive Officer Dr Tapuwa Magure announced the new development at a NAC progress review management meeting. “ WHO has released new ART guidelines, recommending ART initiation to be done using CD4 count of 500 up from 350. As a country we will review and adopt this recommendation.”